These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Implications of changing national cholesterol education program goals for the treatment and control of hypercholesterolemia. Persell SD; Lloyd-Jones DM; Baker DW J Gen Intern Med; 2006 Feb; 21(2):171-6. PubMed ID: 16390501 [TBL] [Abstract][Full Text] [Related]
5. Managing drug therapy: new insights into the National Cholesterol Education Program guidelines. Miller NH AAOHN J; 1994 Mar; 42(3):108-12. PubMed ID: 8147995 [TBL] [Abstract][Full Text] [Related]
6. Improving cholesterol control in managed care populations. McKenney JM Am J Manag Care; 2000 Nov; 6(19 Suppl):S997-1007. PubMed ID: 11187371 [TBL] [Abstract][Full Text] [Related]
7. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
8. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
9. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
10. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
11. Management of high blood cholesterol levels in Nova Scotian adults: comparison with the NCEP II and European clinical practice guidelines. Kephart G; Sketris I; MacLean D; Kass K; Nagpal S Am J Manag Care; 2000 Sep; 6(9):1017-28. PubMed ID: 11184063 [TBL] [Abstract][Full Text] [Related]
12. The National Cholesterol Education Program pediatric guidelines: behavioral considerations. Rosenthal SL; Knauer-Black S; Stahl MP; Catalanoto TJ; Sprecher DL J Dev Behav Pediatr; 1992 Aug; 13(4):288-9. PubMed ID: 1506470 [No Abstract] [Full Text] [Related]
13. Management of hypercholesterolemia in childhood and adolescence. Kronn DF; Sapru A; Satou GM Heart Dis; 2000; 2(5):348-53. PubMed ID: 11728281 [TBL] [Abstract][Full Text] [Related]
14. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
15. [Current developments in prevention of coronary heart disease]. Windler E Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967 [TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy for hypercholesterolemia: guidelines and nursing perspectives. Stoy DB J Cardiovasc Nurs; 1991 Jan; 5(2):34-43. PubMed ID: 1987332 [TBL] [Abstract][Full Text] [Related]
17. [The National Cholesterol Education Program]. Brown V Arzneimittelforschung; 1990 Mar; 40(3A):395-9. PubMed ID: 2185773 [TBL] [Abstract][Full Text] [Related]